Business Context and Reporting Period
Myomo, Inc. (MYO) filed a Form 8-K on February 18, 2025, reporting the entry into a material definitive agreement. The company is incorporated in Delaware and trades on the NYSE American.
Key Financial Metrics and Debt Structure
This filing details a new financing arrangement rather than operational financial results. Key debt metrics include:
- New Term Loan Facility: Up to $3,000,000 available until February 28, 2026.
- Repayment Terms: 36 equal monthly installments of principal plus interest commencing March 1, 2026, with a final maturity date of February 1, 2029.
- Interest Rate: Floating rate equal to the greater of 5.0% or the prime rate minus 1.0%.
- Prepayment Terms: Prepayment premium ranges from 1.0% to 3.0% depending on the year; a 2.50% end-of-term charge applies to prepaid or repaid principal.
- Revolving Line of Credit Changes: Increased limits for Medicare receivables concentration and increased permitted aggregate maximum balance for the German subsidiary.
The filing does not provide current revenue, profit, cash flow, or liquidity figures.
Material Changes Versus Prior Period
The material change is the amendment to the Loan and Security Agreement originally dated July 11, 2024, with Silicon Valley Bank (a division of First-Citizens Bank and Trust Company). This amendment introduces the new term loan facility and modifies the existing revolving line of credit parameters.
Outlook, Risks, and Management Commentary
Management commentary is limited to the description of the loan amendment. The filing notes that the description is qualified in its entirety by reference to the full text of the amendment filed as Exhibit 10.1. No specific guidance, risk factors, or contingencies beyond the terms of the loan agreement are disclosed in this text.
Key Facts for Investor Verification
- Verify the full terms of the First Amendment to the Loan and Security Agreement in Exhibit 10.1.
- Confirm the impact of the new $3,000,000 term loan on the company's total debt load and future cash flow obligations starting in 2026.
- Review the specific conditions regarding the increased concentration of Medicare receivables and the German subsidiary balance limits.
- Monitor the floating interest rate exposure based on the prime rate versus the 5.0% floor.